Ligand-Coupled Lipoprotein for Ovarian Cancer-Specific Drug Delivery
Lipoproteins are natural nanosized delivery vehicles within the circulatory system of all mammals. Scientists have long been interested in utilizing these endogenous macromolecules to transport exogenous imaging or therapeutic agents to specific cells or tissues in the body. The broad distribution of lipoprotein receptors throughout the body however has limited the utility of this approach for targeted delivery of medicinal agents. In recent years lipoprotein rerouting strategies have been developed wherein lipoproteins can be redirected from their natural lipoprotein receptors to an alternate receptor of choice. In this chapter we describe the basic methods of preparing folic acid-conjugated high-density lipoprotein nanoparticles for targeted delivery of imaging or chemotherapeutic agents to ovarian cancer cells.
- Mutational Analysis of Oncogenes and Tumor Suppressor Genes in Human Cancer Using Denaturing Gradient Gel Electrophoresis
- Adenovirus-Mediated Drug-Sensitivity Gene Therapy for Hepatocellular Carcinoma
- 18 Direct Sequencing for Cowden Syndrome Gene PTEN (MMAC1) Mutations
- Immunoscope Analysis of T-Lymphocytes Infiltrating Melanocytic Tumors
- Background, Methods, and Protocols for the Histopathological Diagnosis of Prostate Carcinoma
- Polymeric Micelles: Polyethylene Glycol-Phosphatidylethanolamine (PEG-PE)-Based Micelles as an Example
- Approaches for Monitoring Signal Transduction Changes in Normal and Cancer Cells
- 骨髓瘤细胞的体内接种问题
- 甲醇酵母系统表达的影响因素
- Generation of p53 Target Database Via Integration of Microarray and Global p53 DNA-Binding Site Analysis